Facetten
Zugriff
Einrichtung
Medientyp
- Text 3
Karte
Erscheinungsjahr
- 2014 3
Autor/in
- Hanfstein, Benjamin 3
- Lauseker, Michael 3
- Müller, Martin C 3
- Proetel, Ulrike 3
- Schreiber, Annette
- alle zeigen
Sprache
- Englisch 3
3 Einträge gefunden
-
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV
- Hehlmann, Rüdiger
- Müller, Martin C
- Lauseker, Michael
- Hanfstein, Benjamin
- Fabarius, Alice
- Schreiber, Annette
- Proetel, Ulrike
-
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV
- Proetel, Ulrike
- Pletsch, Nadine
- Lauseker, Michael
- Müller, Martin C
- Hanfstein, Benjamin
- Krause, Stefan W
- Kalmanti, Lida
-
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV
- Kalmanti, Lida
- Saussele, Susanne
- Lauseker, Michael
- Proetel, Ulrike
- Müller, Martin C
- Hanfstein, Benjamin
- Schreiber, Annette